Skip to content
MedCompare

Glycopyrrolate Formoterol Fum

Asthma & Respiratory
Save $1,005/mo
8× cheaper

A combination inhaler (glycopyrrolate and formoterol) used to relieve airflow obstruction in chronic obstructive pulmonary disease (COPD).

United States
$1,156
per month
India
$151
per month
You save
$1,005
87% cheaper in India
125.1K US scripts/yr$125.7M potential annual savings$144.6M US spend/yr
Building 3D structure…
Drag to rotate · 3D structureC19H28BrNO3

SMILES: C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C.[Br-]

Compare the price
US price$1,156per month
India price$151per month
You save$1,00587% less

Based on 30 units per month. US $38.54 vs India $5.04 per unit.

Total over 1 periodSave $1,005$1,156 → $151
Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Medicine savings over 6 months
$6,030
Estimated travel cost
− $2,300
Net savings after travel
$3,730

Even after travel, you could come out ahead by about $3,730.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Glycopyrrolate Formoterol Fum is filled about 125.1K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$144.6M
If sourced from India
$18.9M
Potential annual savings
$125.7M
−87%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.